Corporate News     10-Nov-23
Biocon Biologics divests its non-crore branded formulations biz in India
Biocon Biologics, a subsidiary of Biocon has divested the businesses in relation to its non-core branded formulations in India, comprising, inter alia, of generic dermatology and nephrology small molecule formulations (BFI Non-Core Business) to Eris Lifesciences on a ‘slump sale' basis.
Previous News
  Stock alert: Sapphire Foods, ICICI Bank, Adani Power, Rail Vikas Nigam
 ( Market Commentary - Stock Alert 04-Jun-24   08:42 )
  Biocon signs distribution and supply agreement with Medix
 ( Corporate News - 13-May-24   09:36 )
  Stock Alert: Indegene, Wipro, Biocon, HUDCO
 ( Market Commentary - Stock Alert 13-May-24   08:28 )
  Biocon Ltd rises for third consecutive session
 ( Hot Pursuit - 20-Aug-24   13:05 )
  Biocon Ltd soars 3.74%, rises for third straight session
 ( Hot Pursuit - 02-Jan-24   13:05 )
  Biocon inks pact with Medix to commercialize weight mgmt product
 ( Hot Pursuit - 13-May-24   08:05 )
  Biocon to declare Quarterly Result
 ( Corporate News - 11-Jan-24   11:42 )
  Biocon Ltd spurts 0.78%, up for five straight sessions
 ( Hot Pursuit - 08-Nov-23   13:01 )
  Biocon Ltd soars 1.18%, Gains for third straight session
 ( Hot Pursuit - 26-Dec-23   13:05 )
  Board of Biocon to consider NCD issuance and investment in Biocon Biologics
 ( Corporate News - 24-Apr-23   09:50 )
  Biocon arm completes integration of Viatris biosimilars biz
 ( Hot Pursuit - 07-Sep-23   09:45 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top